1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Investment Feasibility Matrix
    3.6. PESTLE and Porter’s Analysis
    3.7. Regulatory Landscape
        3.7.1. By Key Regions
        3.7.2. By Key Countries
    3.8. Regional Parent Market Outlook
4. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast, 2022-2032
    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Device Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Mn) Analysis By Device Type, 2017-2021
    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Device Type, 2022-2032
        5.3.1. Reprocessed Devices
            5.3.1.1. Hospital
            5.3.1.2. Others
            5.3.1.3. SNP Analysis
            5.3.1.4. Mutational Analysis
            5.3.1.5. Microarray Analysis
            5.3.1.6. RNA Interference
        5.3.2. Other Device Types
    5.4. Y-o-Y Growth Trend Analysis By Device Type, 2017-2021
    5.5. Absolute $ Opportunity Analysis By Device Type, 2022-2032
6. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Service
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Mn) Analysis By Service, 2017-2021
    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service, 2022-2032
        6.3.1. Extractable and Leachable
        6.3.2. Material Characterization
        6.3.3. Physical Testing
        6.3.4. Bioburden Testing
        6.3.5. Sterility Testing
        6.3.6. Other Services
    6.4. Y-o-Y Growth Trend Analysis By Service, 2017-2021
    6.5. Absolute $ Opportunity Analysis By Service, 2022-2032
7. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Therapeutic Areas
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Mn) Analysis By Therapeutic Areas, 2017-2021
    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapeutic Areas, 2022-2032
        7.3.1. Cardiology
        7.3.2. Diagnostic Imaging
        7.3.3. Orthopedic
        7.3.4. IVD
        7.3.5. Ophthalmic
        7.3.6. General & Plastic Surgery
        7.3.7. Drug Delivery
        7.3.8. Endoscopy
        7.3.9. Dental
        7.3.10. Diabetes Care
        7.3.11. Other Therapeutic Areass
    7.4. Y-o-Y Growth Trend Analysis By Therapeutic Areas, 2017-2021
    7.5. Absolute $ Opportunity Analysis By Therapeutic Areas, 2022-2032
8. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2017-2021
    8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2022-2032
        8.3.1. Hospital
        8.3.2. Other End-uses
    8.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021
    8.5. Absolute $ Opportunity Analysis By End-use, 2022-2032
9. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
    9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Europe
        9.3.4. Asia Pacific
        9.3.5. Middle East and Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        10.2.1. By Country
            10.2.1.1. U.S.
            10.2.1.2. Canada
        10.2.2. By Device Type
        10.2.3. By Service
        10.2.4. By Therapeutic Areas
        10.2.5. By End-use
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Device Type
        10.3.3. By Service
        10.3.4. By Therapeutic Areas
        10.3.5. By End-use
    10.4. Key Takeaways
11. Latin America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Device Type
        11.2.3. By Service
        11.2.4. By Therapeutic Areas
        11.2.5. By End-use
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Device Type
        11.3.3. By Service
        11.3.4. By Therapeutic Areas
        11.3.5. By End-use
    11.4. Key Takeaways
12. Europe Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. U.K.
            12.2.1.3. France
            12.2.1.4. Spain
            12.2.1.5. Italy
            12.2.1.6. Russia
            12.2.1.7. Rest of Europe
        12.2.2. By Device Type
        12.2.3. By Service
        12.2.4. By Therapeutic Areas
        12.2.5. By End-use
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Device Type
        12.3.3. By Service
        12.3.4. By Therapeutic Areas
        12.3.5. By End-use
    12.4. Key Takeaways
13. Asia Pacific Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        13.2.1. By Country
            13.2.1.1. China
            13.2.1.2. Japan
            13.2.1.3. India
            13.2.1.4. South Korea
            13.2.1.5. Australia
            13.2.1.6. Rest of APAC
        13.2.2. By Device Type
        13.2.3. By Service
        13.2.4. By Therapeutic Areas
        13.2.5. By End-use
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Device Type
        13.3.3. By Service
        13.3.4. By Therapeutic Areas
        13.3.5. By End-use
    13.4. Key Takeaways
14. Middle East and Africa Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        14.2.1. By Country
            14.2.1.1. South Africa
            14.2.1.2. Saudi Arabia
            14.2.1.3. UAE
            14.2.1.4. Israel
            14.2.1.5. Rest of MEA
        14.2.2. By Device Type
        14.2.3. By Service
        14.2.4. By Therapeutic Areas
        14.2.5. By End-use
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Device Type
        14.3.3. By Service
        14.3.4. By Therapeutic Areas
        14.3.5. By End-use
    14.4. Key Takeaways
15. Key Countries Medical Device Analytical Testing Outsourcing Market Analysis
    15.1. U.S.
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2021
            15.1.2.1. By Device Type
            15.1.2.2. By Service
            15.1.2.3. By Therapeutic Areas
            15.1.2.4. By End-use
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2021
            15.2.2.1. By Device Type
            15.2.2.2. By Service
            15.2.2.3. By Therapeutic Areas
            15.2.2.4. By End-use
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2021
            15.3.2.1. By Device Type
            15.3.2.2. By Service
            15.3.2.3. By Therapeutic Areas
            15.3.2.4. By End-use
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2021
            15.4.2.1. By Device Type
            15.4.2.2. By Service
            15.4.2.3. By Therapeutic Areas
            15.4.2.4. By End-use
    15.5. Germany
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2021
            15.5.2.1. By Device Type
            15.5.2.2. By Service
            15.5.2.3. By Therapeutic Areas
            15.5.2.4. By End-use
    15.6. U.K.
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2021
            15.6.2.1. By Device Type
            15.6.2.2. By Service
            15.6.2.3. By Therapeutic Areas
            15.6.2.4. By End-use
    15.7. France
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2021
            15.7.2.1. By Device Type
            15.7.2.2. By Service
            15.7.2.3. By Therapeutic Areas
            15.7.2.4. By End-use
    15.8. Spain
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2021
            15.8.2.1. By Device Type
            15.8.2.2. By Service
            15.8.2.3. By Therapeutic Areas
            15.8.2.4. By End-use
    15.9. Italy
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2021
            15.9.2.1. By Device Type
            15.9.2.2. By Service
            15.9.2.3. By Therapeutic Areas
            15.9.2.4. By End-use
    15.10. Russia
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2021
            15.10.2.1. By Device Type
            15.10.2.2. By Service
            15.10.2.3. By Therapeutic Areas
            15.10.2.4. By End-use
    15.11. China
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2021
            15.11.2.1. By Device Type
            15.11.2.2. By Service
            15.11.2.3. By Therapeutic Areas
            15.11.2.4. By End-use
    15.12. Japan
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2021
            15.12.2.1. By Device Type
            15.12.2.2. By Service
            15.12.2.3. By Therapeutic Areas
            15.12.2.4. By End-use
    15.13. India
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2021
            15.13.2.1. By Device Type
            15.13.2.2. By Service
            15.13.2.3. By Therapeutic Areas
            15.13.2.4. By End-use
    15.14. South Korea
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2021
            15.14.2.1. By Device Type
            15.14.2.2. By Service
            15.14.2.3. By Therapeutic Areas
            15.14.2.4. By End-use
    15.15. Australia
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2021
            15.15.2.1. By Device Type
            15.15.2.2. By Service
            15.15.2.3. By Therapeutic Areas
            15.15.2.4. By End-use
    15.16. South Africa
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2021
            15.16.2.1. By Device Type
            15.16.2.2. By Service
            15.16.2.3. By Therapeutic Areas
            15.16.2.4. By End-use
    15.17. Saudi Arabia
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2021
            15.17.2.1. By Device Type
            15.17.2.2. By Service
            15.17.2.3. By Therapeutic Areas
            15.17.2.4. By End-use
    15.18. UAE
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2021
            15.18.2.1. By Device Type
            15.18.2.2. By Service
            15.18.2.3. By Therapeutic Areas
            15.18.2.4. By End-use
    15.19. Israel
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2021
            15.19.2.1. By Device Type
            15.19.2.2. By Service
            15.19.2.3. By Therapeutic Areas
            15.19.2.4. By End-use
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Device Type
        16.3.3. By Service
        16.3.4. By Therapeutic Areas
        16.3.5. By End-use
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. SGS SA
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
        17.1.2. Toxikon, Inc.
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
        17.1.3. Eurofins Scientific
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
        17.1.4. Pace Analytical Services LLC
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
        17.1.5. Intertek Group plc
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
        17.1.6. Wuxi AppTec
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
        17.1.7. Envigo
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
        17.1.8. Charles River Laboratories
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
        17.1.9. Medical Device Testing Services
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

-gr.jpg)

 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			